Evidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B)
| dc.contributor.author | Lin, S. | |
| dc.contributor.author | Sanchez-Bretaño, A. | |
| dc.contributor.author | Leslie, J.S. | |
| dc.contributor.author | Williams, K.B. | |
| dc.contributor.author | Lee, H. | |
| dc.contributor.author | Thomas, N.S. | |
| dc.contributor.author | Callaway, J. | |
| dc.contributor.author | Deline, J. | |
| dc.contributor.author | Ratnayaka, J.A. | |
| dc.contributor.author | Baralle, D. | |
| dc.contributor.author | Schmitt, M.A. | |
| dc.contributor.author | Norman, C.S. | |
| dc.contributor.author | Hammond, S. | |
| dc.contributor.author | Harlalka, G.V. | |
| dc.contributor.author | Ennis, S. | |
| dc.contributor.author | Cross, H.E. | |
| dc.contributor.author | Wenger, O. | |
| dc.contributor.author | Crosby, A.H. | |
| dc.contributor.author | Baple, E.L. | |
| dc.contributor.author | Self, J.E. | |
| dc.date.accessioned | 2022-03-04T22:48:53Z | |
| dc.date.available | 2022-03-04T22:48:53Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | Lin, S., Sanchez-Bretaño, A., Leslie, J. S., Williams, K. B., Lee, H., Thomas, N. S., Callaway, J., Deline, J., Ratnayaka, J. A., Baralle, D., Schmitt, M. A., Norman, C. S., Hammond, S., Harlalka, G. V., Ennis, S., Cross, H. E., Wenger, O., Crosby, A. H., Baple, E. L., & Self, J. E. (2022). Evidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B). Npj Genomic Medicine. | |
| dc.identifier.issn | 2056-7944 | |
| dc.identifier.doi | 10.1038/s41525-021-00275-9 | |
| dc.identifier.uri | http://hdl.handle.net/10150/663479 | |
| dc.description.abstract | Oculocutaneous albinism type 1 (OCA1) is caused by pathogenic variants in the TYR (tyrosinase) gene which encodes the critical and rate-limiting enzyme in melanin synthesis. It is the most common OCA subtype found in Caucasians, accounting for ~50% of cases worldwide. The apparent ‘missing heritability’ in OCA is well described, with ~25–30% of clinically diagnosed individuals lacking two clearly pathogenic variants. Here we undertook empowered genetic studies in an extensive multigenerational Amish family, alongside a review of previously published literature, a retrospective analysis of in-house datasets, and tyrosinase activity studies. Together this provides irrefutable evidence of the pathogenicity of two common TYR variants, p.(Ser192Tyr) and p.(Arg402Gln) when inherited in cis alongside a pathogenic TYR variant in trans. We also show that homozygosity for the p.(Ser192Tyr)/p.(Arg402Gln) TYR haplotype results in a very mild, but fully penetrant, albinism phenotype. Together these data underscore the importance of including the TYR p.(Ser192Tyr)/p.(Arg402Gln) in cis haplotype as a pathogenic allele causative of OCA, which would likely increase molecular diagnoses in this missing heritability albinism cohort by 25–50%. © 2022, The Author(s). | |
| dc.language.iso | en | |
| dc.publisher | Nature Research | |
| dc.rights | Copyright © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License. | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
| dc.title | Evidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B) | |
| dc.type | Article | |
| dc.type | text | |
| dc.contributor.department | Department of Ophthalmology, University of Arizona College of Medicine | |
| dc.identifier.journal | npj Genomic Medicine | |
| dc.description.note | Open access journal | |
| dc.description.collectioninformation | This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu. | |
| dc.eprint.version | Final published version | |
| dc.source.journaltitle | npj Genomic Medicine | |
| refterms.dateFOA | 2022-03-04T22:48:53Z |

